Science

THREE ARTICLES DESCRIBING DETAILS OF THE EBOLA VIRUS AND OTHER VIRUSES.
(Scroll Down)

Advances in microscopy have allowed scientists like Sriram Subramaniam and colleagues at the National Cancer Institute to look at the workings of tiny viruses. In this case, microscopy was used to illustrate the complex process in which human cells infected with HIV-1, green and blue, are linked to uninfected cells. Credit Illustration by Donald Bliss/N.I.H, from The Journal of Virology/American Society for Microbiology

The research on how the virus spreads is not as ambiguous as some have made it seem

THE ATLANTIC                                                                                                          Oct. 28, 2014

CDC                                                              Posted Oct. 20, 2014 from  CDC  Oct. 17 document

This document is a concise summary of published information on the current science about human-to-human transmission of Ebola virus. It is developed for use by healthcare personnel and public health professionals to use. It is a complement to the many guidance documents that CDC has issued already online at

www.cdc.gov/ebola.

HUFFINGTON POST

By Sam Stein                                                              Updated Oct. 13 ,2014

BETHESDA, Md. -- As the federal government frantically works to combat the Ebola outbreak in West Africa, and as it responds to a second diagnosis of the disease at home, one of the country's top health officials says a vaccine likely would have already been discovered were it not for budget cuts.

Dr. Francis Collins, the head of the National Institutes of Health, said that a decade of stagnant spending has "slowed down" research on all items, including vaccinations for infectious diseases. As a result, he said, the international community has been left playing catch-up on a potentially avoidable humanitarian catastrophe.

"NIH has been working on Ebola vaccines since 2001. It's not like we suddenly woke up and thought, 'Oh my gosh, we should have something ready here,'" Collins told The Huffington Post on Friday. "Frankly, if we had not gone through our 10-year slide in research support, we probably would have had a vaccine in time for this that would've gone through clinical trials and would have been ready."

By Simon Engler - SEP 4, 2014 - 05:06 PM

Patrick Sawyer, Nigeria's first Ebola patient, collapsed at the international airport in Lagos on July 20. This Wednesday, more than six weeks later, the World Health Organization (WHO) said that it was monitoring at least 200 Nigerians for infection related to Sawyer's case. Sawyer, a Liberian-American who had traveled from Monrovia, had carried the often-fatal disease to Africa's most populous country, hundreds of miles from its origin. It was as if he had slipped through a crowd.

http://blog.foreignpolicy.com/posts/2014/09/04/the_ebola_outbreak_is_out_of_control_can_it_be_tracked_remotely